| DC Field | Value | Language |
|---|
| dc.contributor.author | Fitilev, S. B. | - |
| dc.contributor.author | Shkrebniova, I. I. | - |
| dc.contributor.author | Kliuev, D. A. | - |
| dc.date.accessioned | 2026-10-13T07:03:03Z | - |
| dc.date.available | 2026-10-13T07:03:03Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | Fitilev, S.B. From PDC to integral quantitative metrics: an innovative approach to assessing adherence to combination pharmacotherapy in outpatient practice / S.B. Fitilev, I.I. Shkrebniova, D.A. Kliuev // Research Results in Pharmacology. - 2026. - Vol.12, №2.-P. 1-10. - DOI: 10.18413/rrpharmacology.12.1102. - Refer.: p. 9. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67116 | - |
| dc.description.abstract | Aim: To develop a set of integral metrics analogous to key pharmacokinetic (PK) parameters – area under the concentration-time curve (AUC, area under the curve), maximum concentration (Cmax), and time to maximum concentration (Tmax) – to assess adherence to combination therapy as time-based exposure on the PDC methodology among outpatients | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | heart failure | ru |
| dc.subject | acute myocardial infarction | ru |
| dc.subject | medication adherence | ru |
| dc.subject | combination therapy | ru |
| dc.subject | treatment trajectories | ru |
| dc.subject | pharmacokinetic approach | ru |
| dc.title | From PDC to integral quantitative metrics: an innovative approach to assessing adherence to combination pharmacotherapy in outpatient practice | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 2
|
